Odile Prigneau
Director Ejecutivo en Prestizia SASU .
Perfil
Odile Prigneau is currently the Chief Executive Officer at Prestizia SASU since 2013.
Prior to this, she worked as the Director of Marketing and Business Development at Theradiag SA. She holds a doctorate degree from the Université de Paris 5 René Descartes.
Cargos activos de Odile Prigneau
| Empresas | Cargo | Inicio |
|---|---|---|
Prestizia SASU
 Prestizia SASU Miscellaneous Commercial ServicesCommercial Services Part of Biosynex SA, Prestizia SASU is a French company that provides biotechnology research and development services. The company is based in Paris, France. Odile Prigneau has been the CEO of the company since 2013. Prestizia was acquired by Theradiag SA, a subsidiary of Biosynex SA from Truffle Capital SAS on June 27, 2012. | Director Ejecutivo | 18/09/2013 |
Antiguos cargos conocidos de Odile Prigneau.
| Empresas | Cargo | Fin |
|---|---|---|
| THERADIAG | Corporate Officer/Principal | - |
Formación de Odile Prigneau.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 3 |
|---|---|
Theradiag SA
 Theradiag SA Medical SpecialtiesHealth Technology Theradiag SA engages in the distribution, development, and manufacturing of in vitro diagnostic and theranostics tests. It operates through the following segments: Theranostics and Diagnostics. The Theranostics segment offers solutions for patients treated with anti-tumour necrosis factor alpha. The Diagnostics segment includes products for anti-immunity, genetics, allergy, infectious disease, drug of abuse, other diagnoses, and instrumentation. The company was founded on December 29, 1986 and is headquartered in Croissy-Beaubourg, France. | Health Technology |
| Université de Paris 5 René Descartes | Consumer Services |
Prestizia SASU
Prestizia SASU Miscellaneous Commercial ServicesCommercial Services Part of Biosynex SA, Prestizia SASU is a French company that provides biotechnology research and development services. The company is based in Paris, France. Odile Prigneau has been the CEO of the company since 2013. Prestizia was acquired by Theradiag SA, a subsidiary of Biosynex SA from Truffle Capital SAS on June 27, 2012. | Commercial Services |
- Bolsa de valores
- Insiders
- Odile Prigneau
